| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| 2024 | 2023 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Human Genome Research | 000 | 19 | 2/28/2024 | NON-COMPETING CONTINUATION | $34,932 |
| 2024 | 2023 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Human Genome Research | 001 | 19 | 3/21/2024 | NON-COMPETING CONTINUATION | -$34,932 |
|
| Issue Date FY: 2023 ( Subtotal = $1,547,206 ) |
| 2023 | 2023 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02115 | SUFFOLK | USA | Human Genome Research | 001 | 19 | 3/10/2023 | NON-COMPETING CONTINUATION | $1,319,702 |
| 2023 | 2023 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Human Genome Research | 002 | 19 | 9/6/2023 | SUPPLEMENT FOR EXPANSION | $227,504 |
| 2023 | 2022 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02115 | SUFFOLK | USA | Human Genome Research | 000 | 18 | 11/21/2022 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,324,035 ) |
| 2022 | 2022 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02115 | SUFFOLK | USA | Human Genome Research | 000 | 18 | 4/29/2022 | NON-COMPETING CONTINUATION | $1,324,035 |
| 2022 | 2022 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02115 | SUFFOLK | USA | Human Genome Research | 001 | 18 | 6/14/2022 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,007,878 ) |
| 2021 | 2021 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02115 | SUFFOLK | USA | Human Genome Research | 001 | 17 | 8/26/2021 | COMPETING CONTINUATION | $671,947 |
| 2021 | 2021 | DANA-FARBER CANCER INSTITUTE, INC. | 450 BROOKLINE AVE | BOSTON | MA | 02115 | SUFFOLK | USA | Human Genome Research | 000 | 17 | 3/12/2021 | COMPETING CONTINUATION | $1,335,931 |
|
|